IVF Services Market Overview:
In vitro fertilization (IVF) services market was valued at $9,015 million in 2015, and is expected to reach $17,714 million by 2022, supported by a CAGR of 10.2% during the forecast period 2014 - 2022. In vitro fertilization (IVF) services is the process of artificial fertilization used to treat infertility or genetic problems globally. It is the most efficient assisted reproductive technology (ART), helping couples or single parents around the world.
However, IVF does not always give successful results and its success rate varies from individual to individual. It has emerged as a preferable choice for fertility treatments in the clinical industry. Approximately, 1.5% of babies born in the U.S. are through ART. This procedure is performed in a clinical laboratory where the matured egg (self-egg or donor’s egg) is fertilized with the sperm (self-sperm or donor’s sperm). The fertilized egg or embryo is then implanted into the uterus.
The market growth is attributed to the reduced conceiving rates, mainly in women aged 40 years or above, ovulation disorder, premature ovarian failure, uterine fibroids, damaged or blocked fallopian tube, endometriosis, impaired sperm production or function and unexplained infertility. The encouraging factors such as increase in government interventions and support and delayed parenthood opted by couples due to professional and financial constraints are expected to fuel the market growth. However, ethical concerns in particular countries with respect to IVF, high cost of the IVF procedure, followed by low awareness, especially in underdeveloped economies are expected to hinder the market growth.
In Vitro Fertilization Market Segmentation
This report segments the global IVF market on the basis of cycle type, end user, and geography. On the basis of cycle type, market is classified into fresh cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycles. Fresh cycle (non-donor) is the highest revenue-generating segment, and is expected to maintain this trend with a high growth rate throughout the analysis period. As it is the most common method in an IVF process. Similarly, by end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. The geographical segmentation of the market includes North America, Europe, Asia-Pacific and LAMEA.
The report takes into account the costs of IVF procedures and the total revenue generated through IVF procedures. The total number of IVF cycles performed in the regional market is estimated from 2014 to 2022. This report presents data on the number of embryo transfers undergone by patients during IVF procedures. In addition, it depicts the trend analysis in various regions, which is expected to assist key players to plan their strategies. However, this report excludes revenue generated by fertility medications and the costs of other medication incurred during IVF treatments.
Geographical Market Scenario:
Geographically, the market is segmented across North America, Europe, Asia-Pacific, and LAMEA regions. In terms of number of IVF cycles performed, Asia-Pacific is estimated to dominate the IVF market throughout the analysis period and is set to grow at a prominent CAGR of 13.0%, due to wide availability of IVF clinics, high IVF success rates, and the rising trend of fertility tourism. Japan leads the Asia-Pacific IVF services market, accounting for majority of the market share, and is expected to maintain its position during the analysis period. In terms of revenue, Europe dominated the market in 2015, owing to the favorable reimbursement scenario, and is expected to grow at a CAGR of 5.4%, in terms of revenue.
Latin America IVF Services Market, By End User, 2015 ($Million)
Latin American countries such as Brazil, Colombia, and Venezuela do not provide reimbursements for ART treatment. In Argentina, currently, there is no reimbursement policy available for ARTs; however, partial reimbursements are provided for ovulation induction therapies. Most of the medical treatments in Latin American countries are provided in the public sector. Fertility clinics contributed to highest number of IVF cycles in 2015. However, the impending need for advanced IVF treatments is expected to elevate the growth rate of the clinical research institutes segment to 13.5%, which is the fastest amongst other end user segments.
End User Market Scenario:
Fertility clinics accounted for a major market share in 2015, and is projected to maintain this trend over the forecast period. This is attributed to the rise in the number of fertility clinics as well as the availability of a wide range of fertility treatments under a single roof coupled with government reimbursements. Fertility clinics is followed by hospitals, and together they occupied over three-fourths share of the overall market share in 2015.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET KEY BENEFITS
- The report provides an in-depth analysis of the IVF market across 20 major countries, with a cross-sectional analysis of the number of IVF cycles performed and total revenue generated during the forecast period.
- The report assists in understanding the strategies adopted by various IVF clinics and hospitals to gain a higher market share.
- The projections in the report are made by analyzing the current trends and highlighting the market potential from 2014 to 2022, in terms of value and volume.
- Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
- In-depth analysis of insurance reimbursement scenario for the IVF procedure highlights the essential strengths and potential opportunities in the market.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET KEY SEGMENTS:
BY CYCLE TYPE
- Fresh Cycle (Non-Donor)
- Thawed IVF Cycle (Non-Donor)
- Donor Egg IVF Cycle
- BY END USER
- Fertility Clinics
- Surgical Centers
- Clinical Research Institutes
- North America
- United States
- United Kingdom
- Others Europe
- New Zealand
- Others APAC
- Latin America
- Middle East